Press Releases

News, Events, Updates, Breakthroughs

Press announcements are archived by release date, searchable by topic:

From To
Date Title
2016.02.02
Daiichi Sankyo to Expand Access to Clinical Trial Data
PDF (100 KB)
2015.12.10
ARQULE AND DAIICHI SANKYO ANNOUNCE COMPLETION OF ACCRUAL IN METIV-HCC PHASE 3 TRIAL OF TIVANTINIB F ...
PDF (308 KB)
2015.11.10
Daiichi Sankyo and Plexxikon Announce FDA Approval of Cobimetinib in Combination with Zelboraf® (ve ...
PDF (327 KB)
2015.11.02
Daiichi Sankyo, Inc. Announces New Subgroup Analyses of Once-Daily SAVAYSA® in Patients with Non-Va ...
PDF (268 KB)
2015.10.30
FDA Grants Breakthrough Therapy Designation for Daiichi Sankyo and Plexxikon’s Investigational CSF- ...
PDF (193 KB)
2015.10.29
Charleston Laboratories, Inc. and Daiichi Sankyo, Inc. Announce Phase 3 Study of CL-108 Met Primary ...
PDF (69 KB)
2015.10.16
Daiichi Sankyo, Inc. Reorganizes its U.S. Commercial Operations to Support Upcoming Specialty Pipel ...
PDF (147 KB)
2015.07.29
Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonge ...
PDF (155 KB)
2015.06.18
Daiichi Sankyo Initiates Hokusai-VTE Cancer Study to Evaluate the Role of Edoxaban in Patients with ...
PDF (124 KB)
2015.05.13
Charleston Laboratories, Inc. and Daiichi Sankyo, Inc. Announce Three Poster Presentations
PDF (630 KB)
Showing 1 - 10 of 16 results.